Mizoribine

This classification denotes an immunosuppressant with the molecular formula C9H13N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 4JR41A10VP, chemically known as 1h-imidazole-4-carboxamide, 5-hydroxy-1-.beta.-d-ribofuranosyl- but more generally known as mizoribine, which bears US NIH Compound Identifier 4213. European Medicines Agency schedules Mizoribine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09019MIG. The term MIZORIBINE is an International Non-Proprietary Name. MIZORIBINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule mizoribine under HS 29349990 and SITC 51579. As of Q4 2014, MIZORIBINE remains US FDA's Preferred Term for this commodity. Mizoribine bears US NLM identifiers UMLS ID C0128608 and NCI Concept Code C66172. SMILES: O1C(N2C(O)C(NC2)C(=O)N)C(O)C(O)C1CO.